OBX · NASDAQ · Biotechnology

Obsidian Therapeutics Inc. (OBX)

$15.84
vs last close−1.16 (−6.85%)

13F · 13D/G · Form 4

No reliable share count is available for this listing, so stakes are shown as shares, not percentages.

13F · 13D/G · Form 4

HolderStakeSharesDate
Deep Track Capital, LPStrategic
5.37% of class, as filedfiled Aug 11, 2026
Novo Holdings A/SStrategic
5.10% of class, as filedfiled Aug 10, 2026
RA Capital Management, L.P.Institution
9.70% of class, as filedfiled Aug 10, 2026

13F

No 13F holders on record.

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
RA Capital Management, L.P.9.70%13GAug 10, 2026
Deep Track Capital, LP5.37%13GAug 11, 2026
Novo Holdings A/S5.10%13GAug 10, 2026

Form 4

Latest trades

No open-market trades in the last 12 months.

House and Senate disclosures

Not reported.